Temsirolimus and Vorinostat in Treating Patients With Metastatic Prostate Cancer

Clinical trial NCT01174199 · TERMINATED

Trial details

NCT number: NCT01174199
Sponsor: Roswell Park Cancer Institute
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Prostate Cancer Adenocarcinoma of the Prostate Hormone-resistant Prostate Cancer Recurrent Prostate Cancer Stage IV Prostate Cancer

Start date: 2012-02-01
Primary completion: 2015-08-01
Enrollment: 13

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.